Internal Medicine, Pulmonary Disease · Oklahoma City, OK
NPI
1154398410
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
9
Medicare group memberships
Hospitals
1
Hospital affiliations
608 NW 9th St, Suite 6200
Oklahoma City, OK, 73102
Phone (405) 272-7677
Groups this clinician bills Medicare through
Medicare paid, 2024
$77K
883 services
Medicare patients, 2024
256
Average age 74
Drug cost, 2024
$839K
2,730 prescriptions
Company payments, 2025
$110
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David R Allen was code 99214 (office e&m - established), 304 times for 162 patients. In total David R Allen billed 883 services in 21 codes, and Medicare paid $77K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-04-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 304 | 162 | $84.29 | $26K |
| 99233 Hospital E&M - Subsequent | Facility | 294 | 59 | $81.46 | $24K |
| 99223 Hospital E&M - Initial | Facility | 86 | 69 | $119.61 | $10K |
| 99215 Office E&M - Established | Office | 63 | 41 | $122.34 | $7,707 |
| 99204 Office E&M - New | Office | 32 | 32 | $111.33 | $3,563 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 17 | $55.53 | $1,444 |
| 99239 Hospital Discharge Management | Facility | 21 | 15 | $76.95 | $1,616 |
By year: 2022 $116K for 1,354 services; 2023 $102K for 1,126 services; 2024 $77K for 883 services.
Medicare prescription drug claims, 2024
In 2024, the drug David R Allen prescribed most often to Medicare patients was Ipratropium Bromide, with 386 prescriptions and refills. In total David R Allen wrote 2,730 Medicare prescriptions that cost $839K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ipratropium Bromide Generic | 386 | 456 | 135 | $9,526 |
| Fluticasone Propionate Generic | 243 | 401 | 100 | $3,696 |
| Prednisone Generic | 234 | 448 | 95 | $1,472 |
| Montelukast Sodium Generic | 201 | 562 | 79 | $4,029 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 136 | 177 | 33 | $110K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 126 | 150 | 36 | $3,560 |
| Potassium Chloride Generic | 69 | 130 | 23 | $1,132 |
| Doxycycline Hyclate Generic | 66 | 67 | 44 | $726 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 60 | 60 | 12 | $1,907 |
| Azithromycin Generic | 59 | 69 | 39 | $584 |
| Furosemide Generic | 55 | 113 | 23 | $308 |
| Torsemide Generic | 47 | 107 | 21 | $1,470 |
| Cephalexin Generic | 41 | 41 | 16 | $290 |
| Eliquis Apixaban | 36 | 46 | 11 | $27K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 30 | 52 | Under 11 | $22K |
Brand drugs: - claims; generic drugs: 2,149 claims; opioid claims: 165.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David R Allen $110 ($110 in general payments such as food, travel and fees) from 3 companies. The largest payer was GlaxoSmithKline, LLC. with $70.93.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.